ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer | Baylor College of Medicine / Stephen Gottschalk, M.D. | Innovation Grants | 2014 | Texas |
Adoptive immunotherapy using clinical-grade T cells. | University of Texas M.D. Anderson Cancer Center / Laurence Cooper, MD, PhD | Innovation Grants | 2007 | Texas |
The Role of MiRNA Impairment in Wilms' Tumor Formation | University of Texas Southwestern Medical Center at Dallas / Kenneth Chen, MD | Young Investigator Grants | 2016 | Texas |
Parallel sequencing to identify the causes of childhood cancer | Baylor College of Medicine / Sharon Plon | Innovation Grants | 2008 | Texas |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene | Baylor College of Medicine / Robin Parihar, MD, PhD | Young Investigator Grants | 2015 | Texas |
STAT3 Signaling Profiles Predict Response to Chemotherapy in Pediatric AML | Baylor College of Medicine / Michele Redell, M.D./Ph.D. | Springboard Grants | 2014 | Texas |
Mechanisms of LYL1-associated T-ALL development | Baylor College of Medicine / Margaret Goodell, PhD | Innovation Grants | 2012 | Texas |
Optimizing Engager T-cells for CD19+ Malignancies | Baylor College of Medicine / Mireya Paulina Velasquez, MD | Young Investigator Grants | 2014 | Texas |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 | Baylor College of Medicine / Andras Heczey, MD | Young Investigator Grants | 2014 | Texas |
Role of Primary Cilium Signaling and Dynamics in Medulloblastoma Initiation and Progression | University of Texas Southwestern Medical Center / Saikat Mukhopadhyay, MD/PhD | 'A' Award Grants | 2016 | Texas |